Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway
<p>Abstract</p> <p>Background</p> <p>Antagonists of growth hormone-releasing hormone (GHRH) are being developed for the treatment of various human cancers.</p> <p>Methods</p> <p>MTT assay was used to test the proliferation of SKOV3 and CaOV3. The...
Saved in:
Main Authors: | Varga Jozsef (Author), Zarandi Marta (Author), Schally Andrew V (Author), Guo Jian (Author), Leung Peter CK (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2010-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diminished ovarian reserve predisposes to premature luteinizing hormone surges in gonadotropin-releasing hormone antagonist cycles in In vitro fertilization
by: Puneet Kaur Kochhar, et al.
Published: (2020) -
Gonadotrophin releasing hormone antagonist in IVF/ICSI
by: M S Kamath, et al.
Published: (2008) -
Comparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders
by: Min Xia, et al.
Published: (2021) -
Growth Hormone-Releasing Hormone and Its Analogues: Significance for MSCs-Mediated Angiogenesis
by: Xiangyang Xia, et al.
Published: (2016) -
The Decreased Growth Hormone Response to Growth Hormone Releasing Hormone in Obesity Is Associated to Cardiometabolic Risk Factors
by: Fernando Cordido, et al.
Published: (2010)